Clinical Evidence for Rebound Hypercoagulability After Discontinuing Oral Anticoagulants for Venous Thromboembolism

CONTEXT: In vitro studies and anecdotal clinical reports have suggested that clinically significant rebound hypercoagulability may occur after discontinuation of oral anticoagulants (OACs), such as vitamin K antagonists and ximelagatran, for venous thromboembolism (VTE). OBJECTIVE: Assess the extent...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Cundiff, David Keith
Médium: Artigo
Jazyk:Inglês
Vydáno: Medscape 2008
Témata:
Departments
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605115/
https://ncbi.nlm.nih.gov/pubmed/19099008
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky